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Why corporate power is a public health priority
The marketing campaigns of multinational corporations are harming our physical, mental, and
collective wellbeing. Gerard Hastings urges the public health movement to take action
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The work of Professor Richard Doll provides two key lessons
for public health. The first, that we must do all we can to
eradicate the use of tobacco, has been well learnt and is being
energetically acted upon. The second, more subtle learning—that
our economic system has deep flaws—remains largely ignored.
And yet, lethal though tobacco is, the harm being done to public
health by our economic system is far greater.
Industrial epidemics
Furthermore, the two are intimately connected: tobacco has
remained such an intractable problem only because our
economic system allows free ranging corporations to market it.
The same applies to the other two “industrial epidemics”1 that
constitute such a large share of the public health burden: alcohol
misuse and obesity. In each case evocative promotion,
ubiquitous distribution, perpetual new product development,
and seductive pricing strategies are used to encourage unhealthy
consumption. And in each case painstaking research and review
have shown the obvious truth that this marketing effort succeeds,
especially with the young.2-4 The consequence has been the
inevitable escalation of lifestyle illnesses such as cancer, heart
disease, cirrhosis, and diabetes.
However, the impact of marketing on public health goes much
deeper than this. Marketing textbooks lionise the consumer: our
complete satisfaction is the essence of successful business
(provided we can afford to pay). The result is an unstinting hunt
for new needs and wants (or, increasingly, whims) to satisfy,
and a population that has a burgeoning sense of entitlement.
The damaging effect of this favouritism is shown in the
pharmaceutical business, which paysmore attention to the trivial
complaints of the rich than the life threatening sicknesses of the
poor. As Bakan points out, “Of the 1400 new drugs developed
between 1975 and 1999, only 13 were designed to treat or
prevent tropical diseases and three to treat tuberculosis. In the
year 2000, no drugs were being developed to treat tuberculosis,
compared to eight for impotence or erectile dysfunction and 7
for baldness.”5 This dangerously indulgent focus starts at birth,
because children offer the corporate marketer a lifetime of
profitability (box 1).
Sadly, as any philosopher or theologian would predict, such
pampering does not bring happiness. Once basic needs are
satisfied, the correlation between material possessions and
contentment rapidly dissipates. But marketing keeps us craving
more: the paradox of a system devoted to our satisfaction is that
it depends on our perpetual dissatisfaction; after all once we are
satisfied we stop shopping. In this way it undermines our mental
as well as our physical wellbeing.
The customer always comes second
Furthermore, the corporate marketers’ focus on customer
satisfaction is in reality specious; the fiduciary duty of
corporations gives them a legal obligation to prioritise the needs,
not of the consumer, but of the shareholder. How else could we
have tobacco companies, who are consummate marketers,
continuing to produce products that kill one in two of their most
loyal customers? The corporate marketers’ self centred purpose,
then, is “to recognise and achieve an economic advantage which
endures.”7 Not an economic advantage for the customer—just
for the company. This is the same single minded and
dysfunctional principle that continues to drive the financial
sector.
A key function of marketing is to mask these uncomfortable
truths by disguising inanimate corporate monoliths as benign
friends under the guise of branding. The role of branding in
youth smoking8 and drinking9 has been well documented, and
a recent study in California among 3-5 year olds showed that
children’s food preferences are being moulded by McDonald’s
branding even before they have learnt to tie their shoelaces.10
Items that came in McDonald’s wrappers were thought to taste
better, even if they were foods like carrots; on the other hand
McDonald’s products didn’t taste as good without the liveried
packaging. These effects were apparent across the group, but
most marked among those who had been most exposed to
McDonald’s and its advertising. Marketers are clearly
succeeding in their aim “to start building up their brand
consciousness and loyalty as early as possible.”6
However, susceptibility to the “emotional benefits” of branding
reaches way beyond toddlers and teens; it touches us all. The
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Box 1: How corporate marketers view children
According to a leading business textbook:
“Children are important to marketers for three fundamental reasons:
• They represent a large market in themselves because they have their own money to spend
• They influence their parents’ selection of products and brands
• They will grow up to be consumers of everything; hence marketers need to start building up their brand consciousness and loyalty as
early as possible” 6
2005 Health Select Committee investigation into the
pharmaceutical industry showed that it is even being used to
influence general practitioners’ prescribing practices (figure⇓).
No wonder the committee’s final report expressed “over-riding
concerns about the volume, extent ,and intensity of the industry’s
influence, not only on clinical medicine and research but also
on patients, regulators, the media, civil servants, and
politicians.”11
Collective harm
The harmful consequences of corporate marketing are even
more apparent at a collective level. Marketers, as I noted above,
are only interested in catering for the needs of those with money;
as the business textbooks put it, target markets have to be
accessible, responsive, and (above all) viable. The key concern
is to reach people with persuasive marketing campaigns, and
having done so, be confident that they will be both willing and
able to make the purchase. So even as the “haves” get more, the
“have nots” get less—and the resulting exacerbation of
inequalities damages the health and wellbeing of both rich and
poor.13 The distortions in the pharmaceutical market described
above only serve to underline the systemic nature of the
problem.
Not that disadvantaged groups completely escape the attentions
of corporate marketers. Once the well-off are sated, or become
disenchanted with product offerings, the disadvantaged get their
turn in the sun. So now the beverage alcohol industry has got
people in the developed world consuming as much booze as is
humanly possible, it is turning its attention to developing
countries.14 Similarly the social patterning of smoking in the
UK has led tobacco companies to focus their efforts on poorer
groups—hence the expansion in economy brands and price
promotions.15
On a broader scale, marketers also recognise that context
matters—that norms, mores, and, above all, laws have a big
impact on our consumption behaviour. They therefore market
to stakeholders and politicians in a bid to influence the policy
agenda and thereby undermine what is public health’s most
important armamentarium. The alcohol industry’s activities in
the UK provide an instructive example. Corporate social
responsibility efforts have included the funding of midwife
training, support for non-governmental organisations in areas
such as schools education,16 and addiction services,17 and the
establishment of the Drinkaware Trust (set up to promote “the
facts about alcohol”). All are carefully designed to position the
industry as part of the solution rather than the problem. The
subsequent decision by the UK government to implement its
public health responsibility deal, which has made the alcohol
industry (and other corporate interests) partners in the policy
making process, shows that the strategy worked. It also points
out the potential for public health harm, as an evidence base
that has established the urgent need to reduce per capita
consumption falls prey to the business model that demands
growth.
Thinking more broadly still, the biggest effect that all this
remorseless corporate marketing has on public health comes
even further upstream—at a planetary level. We have built a
system where continuous growth, fed by marketing driven
excess consumption by the alreadywell-off, is inevitably coming
into conflict with the limits of a finite planet. This is now
threatening public health far more seriously than the activities
of any one industry—even one as egregious as tobacco— will
ever do.
Broadening public health
These are massive problems that demand urgent attention and
radical measures. There are some signs that public health is up
for this challenge. The Framework Convention on Tobacco
Control—“theworld’s first global public health treaty”18—shows
that the global reach of corporate power can be controlled.
Similarly, Marmot’s pioneering work on the social determinants
of health shows that there is an appetite for taking a broad
perspective and “turning public health knowledge into political
action.”19 And, more recently, Rayner and Lang have called for
a broader “ecological” perspective which recognises that “public
health is often improved by movements and people prepared to
challenge conventional assumptions and the status quo.”20
However, Rayner and Lang also point out that “public health
remains strangely marginal in public discourse as well as patchy
in execution”20—and there are telling signs that we are failing
to address this larger agenda. Our focus has become increasingly
narrow and technocratic. We are, it seems, happier conducting
randomised controlled trials of leaflet interventions or
calculating algorithms that mean little outside the laboratory
than challenging a system that is both deeply unfair and
hopelessly unsustainable.
Public health workers have also become increasingly fragmented
into disciplinary silos. Tobacco experts rarely speak to those in
alcohol, nutrition, or sexual health, with no apparent recognition
that, far from being unique and separate, the behaviours they
all address comprise a typical Saturday night out for large sectors
of the population. This also blinds us to the importance of
individual empowerment. We beetle away at micromanaging
specific behaviours and ignore the key message emerging from
the public health evidence base—that for the first time in human
history we now know how we can take a measure of control
over our own health and longevity. By the same token we barely
acknowledge the harm being done by our economic system,
which undermines our critical faculties and sense of agency
with perpetual messages of materialism and unwarranted
entitlement. L’Oreal’s corrosive slogan, “Because we are worth
it,” has become the leitmotiv of society on our watch.
It is little surprise, then, that corporate capitalism has gone from
strength to strength and is taking over what should be core public
health roles; we have got the responsibility deals we deserve.
And our timorous protestations at this preferment of the fox to
the keeper of the chicken coop can so easily be brushed aside
because we have no public profile; we jettisoned that along with
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e5124 doi: 10.1136/bmj.e5124 (Published 21 August 2012) Page 2 of 5
ANALYSIS
the Health Education Authority, when we failed to protect it
from government closure.
Indeed, far from tackling and challenging the corporate
marketers, we seem set on doing their bidding. We work with
them on the Drinkaware Trust, in full knowledge that this makes
us no more than junior executives in a textbook example of
stakeholder marketing. The Health Select Committee, having
warned us of the unwarranted influence of the pharmaceutical
industry on our work, thinks it is necessary to stress the need
“to examine critically the industry’s impact on health to guard
against excessive and damaging dependencies.” But we lack
the vision to do so, and even were we to regain it, have ceded
our place at the top table. Our job is to keep quiet and clean up
the mess made by the big boys; we have become janitors when
the urgent need is for janissaries.
Moving beyond the topic specific, where is the public health
contribution to such pressing problems as the corporate takeover
of the Olympics—an event that should be a beacon of healthy
activity not another shopping opportunity—or the debate about
the coalition government abandoning its green agenda; or the
financial crisis and corporate greed? Would a journalist even
think about coming to public health for a comment on any of
these?
As Rayner and Lang argue, public health needs a radical shake
up; we have to revitalise—reinvent—our discipline. This
reinvention has to recognise the increasingly unhealthy
dominance of corporate marketing on our lives; Marmot’s focus
on the social determinants of ill health needs to be matched with
an equal concern for the commercial determinants of ill health.
As a contribution to this debate, I offer the following
suggestions:
Independent public health body—We urgently need to
re-establish a public health body in the UK that is linked to but
clearly untrammelled by government—and completely insulated
from vested interest. We have to start once again speaking
unfettered truth to power. Through this we can also begin to
rebuild a respected relationship with the public; now more than
ever people need a champion to speak up for their real needs,
rather than the phoney ones teased and tempted by corporate
capitalism.
Wider vision—We have to lift our eyes above the quotidian: to
remember that public health is not just about pump handles but
also water resources. We can and should be offering a
geopolitical vision with greater equality as its central pledge.
This vision must consider the relationship between business
and society. Multinational corporations will continue to be an
important part of our economic system, if only because complex
societies need the logistics and efficiencies they can deliver. It
is difficult, for instance, to see how a city like London could
continue to feed itself without supermarkets. However, public
health has a legitimate and crucial role in asking questions about
the extent of their power, the crassness of the fiduciary
imperative, and the almost complete lack of responsibility being
taken for externalities.
Rein in marketing—Unbridled marketing should also be
energetically challenged. If, for example, the advertising of
tobacco can be banned because smoking harms the individual,
should not all advertising be muchmore circumscribed because
the consumption it engenders harms the planet? Similarly,
marketing is currently a right taken for granted; given its effect
on inequalities should it not more properly be seen as a carefully
controlled responsibility? Or again, what would be the pros and
cons of requiring all corporations to show the effect that their
marketing is having on health and welfare?
Challenge profit as a measure of success—More positively, we
should question the legitimacy of marketing, which we know
to be so powerful, being used simply to boost consumption and
corporate profitability. Broader conceptions of success are
needed that move beyond finance and focus instead on human
welfare. Public health is perfectly equipped to lead this new
enlightenment, starting with theWHO’s multifaceted definition
of health as “a state of complete physical, mental and social
wellbeing and not merely the absence of disease or infirmity.”
Regain political leverage—We must demand a seat at the
political top table, not just in health but in finance. Recent events
in the banking sector confirm an age old lesson that fiscal policy
has at least as much effect on morbidity and mortality as
anything done in health ministries. Public health is too important
to be left to economists and politicians, prey as they so obviously
are to the cynical ministrations of the corporate marketer.
Think global—Finally, we have to recognise that our public
health travails in the UK have global echoes and reverberations.
Marketing campaigns have long since superseded mere national
boundaries,WHO has been under well evidenced pressure from
corporate interests for decades,21 and the public health mistakes
we have made in the UKwill be visited ever more energetically
on poorer countries. When we flirt with the corporates
developing countries get ravished. Everything we do should
respect this international agenda and related responsibilities.
An ambitious pitch
I accept this is an ambitious pitch. Public health has to demand
a place at the macroeconomic table; it has to contribute to the
debate about where corporate capitalism is going and ensure
that the public health implications of business decision making
are fully appreciated. The business sector is certainly not shy
of putting forward its view of how the world should be organised
for the greater good of business (see box 2 for example). If
public health can develop a similar boldness of purpose we will
be able to graduate from the post hoc reduction of specific harm,
to a pre-emptive quest for an economic system that actively
promotes better public health. We have to take the lead in a
movement away from a world driven by abeyance to the
corporate bottom line and the enrichment of an elite to one that
prioritises physical, mental, social, and planetary wellbeing.
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Box 2: Leading business thinker Michael Porter presents his new world vision in the Harvard Business Review22
“It is not philanthropy but self-interested behaviour to create economic value by creating societal value. If all companies individually pursued
shared value connected to their particular businesses, society’s overall interests would be served. And companies would acquire legitimacy
in the eyes of the communities in which they operated, which would allow democracy to work as governments set policies that fostered and
supported business.”
The implications of this view for our way of life are profound. For example, Porter emphasises that his new world will certainly not involve
any equalising of current wealth: “Nor is it about ‘sharing’ the value already created by firms—a redistribution approach. Instead, it is about
expanding the total pool of economic and social value.” This is a massive political statement which raises questions about relative rather
than absolute poverty, the current inequities in society (ironically thrown into relief by corporate pay) and the sustainability of perpetual
growth.
Challenges for public health
• Marketing by multinational corporations presents a major threat to public health; children are especially vulnerable
• As well as lifestyle illnesses such as lung cancer and liver cirrhosis, marketing threatens our mental wellbeing, exacerbates inequalities,
and encourages unsustainable consumption
• Public health should take a lead in addressing these issues, revitalise its upstream, political functions, and regain its role as a champion
of the underprivileged
• Public health should also be leading a quest for an economic system that actively promotes better public health
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Figure
Branding prescription drugs: the diagram, which is from internal pharmaceutical industry documents, shows equal importance
being attached to the role of rational and emotional dimensions in the development of strong brands12
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